131 related articles for article (PubMed ID: 26160715)
1. Pure total flavonoids from Citrus paradisi Macfadyen act synergistically with arsenic trioxide in inducing apoptosis of Kasumi-1 leukemia cells in vitro.
Wang B; Lin SY; Shen YY; Wu LQ; Chen ZZ; Li J; Chen Z; Qian WB; Jiang JP
J Zhejiang Univ Sci B; 2015 Jul; 16(7):580-5. PubMed ID: 26160715
[TBL] [Abstract][Full Text] [Related]
2. Pure total flavonoids from Citrus paradisi Macfad induce leukemia cell apoptosis in vitro.
Dai TY; Wang B; Lin SY; Jiang JP; Wu LQ; Qian WB
Chin J Integr Med; 2017 May; 23(5):370-375. PubMed ID: 27465424
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M
Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514
[TBL] [Abstract][Full Text] [Related]
4. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
[No Abstract] [Full Text] [Related]
5. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
6. The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice.
Yu R; Wang D; Ren X; Zeng L; Liu Y
Leuk Res; 2014 Sep; 38(9):1085-90. PubMed ID: 24908354
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell lines.
Yu Q; Chen B; Zhang X; Qian W; Ye B; Zhou Y
Planta Med; 2013 Jun; 79(9):775-81. PubMed ID: 23700110
[TBL] [Abstract][Full Text] [Related]
8. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU.
Subbarayan PR; Lee K; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1157-62. PubMed ID: 20530422
[TBL] [Abstract][Full Text] [Related]
10. Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9.
Chau D; Ng K; Chan TS; Cheng YY; Fong B; Tam S; Kwong YL; Tse E
J Hematol Oncol; 2015 May; 8():46. PubMed ID: 25953102
[TBL] [Abstract][Full Text] [Related]
11. Low-dose 1,25-dihydroxyvitamin D(3) combined with arsenic trioxide synergistically inhibits proliferation of acute myeloid leukemia cells by promoting apoptosis.
Bae JY; Kim JW; Kim I
Oncol Rep; 2013 Jul; 30(1):485-91. PubMed ID: 23660868
[TBL] [Abstract][Full Text] [Related]
12. Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway.
Wang R; Cong WH; Guo G; Li XX; Chen XL; Yu XN; Li H
Chin J Integr Med; 2012 Dec; 18(12):934-41. PubMed ID: 23239002
[TBL] [Abstract][Full Text] [Related]
13. Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis.
Ye Y; Xu X; Zhang M; Qiu D; Bai X; Wang J; Weng G; Zhou R; Guo Z; He H; Yi W; He X; Guo K
Leuk Lymphoma; 2015; 56(11):3159-67. PubMed ID: 25739941
[TBL] [Abstract][Full Text] [Related]
14. [Effect of arsenic trioxide combined with adriamycin on the proliferation and apoptosis of human lymphoma cells].
Huang R; Li X; Huang X; Yang X; Li W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):515-22. PubMed ID: 19587434
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
Chung WH; Sung BH; Kim SS; Rhim H; Kuh HJ
Int J Oncol; 2009 Jun; 34(6):1669-79. PubMed ID: 19424586
[TBL] [Abstract][Full Text] [Related]
16. Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha.
El Eit RM; Iskandarani AN; Saliba JL; Jabbour MN; Mahfouz RA; Bitar NM; Ayoubi HR; Zaatari GS; Mahon FX; De Thé HB; Bazarbachi AA; Nasr RR
Int J Cancer; 2014 Feb; 134(4):988-96. PubMed ID: 23934954
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of arsenic trioxide and sulindac sulfide in A549 human lung cancer cells in vitro.
Jiang TT; Brown SL; Kim JH
J Exp Clin Cancer Res; 2004 Jun; 23(2):259-62. PubMed ID: 15354410
[TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxic effects of arsenic trioxide plus dithiothreitol on mice oral cancer cells.
Tsai CW; Chang NW; Tsai RY; Wang RF; Hsu CM; Lin SS; Wu CN; Sun SS; Tsai MH; Bau DT
Anticancer Res; 2010 Sep; 30(9):3655-60. PubMed ID: 20944150
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
20. Toward adjunctive therapy of acute myeloid leukemia: is it feasible?
Diamantidis MD; Papaioannou M
Leuk Res; 2014 Sep; 38(9):1016-7. PubMed ID: 25063523
[No Abstract] [Full Text] [Related]
[Next] [New Search]